FREE CPD WEBINAR
The Long Shadow of RSV: Infection, Airway Injury, and Lifetime Asthma Risk
Prevention and follow-up in general practice: protecting infant lungs from long-term effects beyond acute infection.
Wednesday 10 June 2026
7:30-9:00pm (VIC, NSW, QLD, ACT, TAS)
7:00-8:30pm (SA, NT)
5:30-7:00pm (WA)
Developed in partnership between National Asthma Council and Praxhub.
Event Countdown
CPD Webinar + Live Q&A
Managing Mycosis Fungoides: Practical Approaches for CTCL Patients in Clinical Practice
Duration: 1 hour
Provider: Praxhub
ID: XXXXXX
ID: XXXXXXX
Dr Jillian Wells
Specialist Dermatologist
Dr Full Name
General Practitioner and Leading Medical Educator
Dr Full Name
Presenter Full Name
Weekday 15 October 2025, 7:30pm AEST
Description:
Join us for a practical webinar with specialist dermatologist Dr Jillian Wells as she provides a comprehensive overview of Mycosis Fungoides (MF), from diagnosis and staging to the latest treatment approaches. The session will explore the role of chlormethine gel and its place in current clinical practice, supplemented by valuable patient case studies. Conclude with a live Q&A where you can get expert answers to all your burning questions.
Learning outcomes:
-
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo
-
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo
-
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo
Continuing Professional Development (CPD) Details
The medical education collection is being developed to Australian medical CPD standards and will offer learners a combination of Educational Activity, Reviewing Performance and Measuring Outcomes education.
Certificates of completion will be available to learners upon successful completion of each activity.
.webp)
Praxhub is an accredited Major Provider under the RACGP CPD Program.
About this education
RSV is responsible for the majority of bronchiolitis cases in Australian infants¹ and sends thousands of children to hospital each year.² Yet the acute illness is only part of the story. Mounting epidemiological and biological evidence links severe early-life RSV infection with recurrent wheezing and asthma³ - a connection that is still debated in terms of causality³ but is increasingly hard to ignore in clinical practice.⁴ At the same time, a new prevention landscape has arrived: NIP-funded maternal RSV vaccination and long-acting monoclonal antibodies now offer genuine primary prevention opportunities that sit squarely within the GP's scope.
This webinar provides Australian GPs and Nurse Practitioners with a clinically grounded, evidence-based framework for understanding the RSV–asthma relationship, implementing current immunoprophylaxis guidelines, counselling families on long-term respiratory risk, and managing the post-RSV child in general practice.
CPD Webinar + Live Q&A
Webinar 2 - title to be confirmed
Duration: 1 hour
Provider: Praxhub
ID: XXXXXX
ID: XXXXXXX
Dr Full Name
General Practitioner and Leading Medical Educator
Dr Full Name
General Practitioner and Leading Medical Educator
Dr Full Name
Presenter Full Name
Weekday XX Month YYYY, 7:30pm AEST
Description:
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Learning outcomes:
-
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo
-
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo
-
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo
Praxhub acknowledges Sanofi for its support of this education. The sponsor has provided no input into the content of this activity.
Learning Outcomes
Upon completion of this education you will be able to:
1
Describe the epidemiological and biological evidence linking severe early-life RSV infection with asthma development, referencing key Australian data.
2
Differentiate the 'marker hypothesis' from the 'causal hypothesis' in the RSV–asthma debate and apply this distinction to parent and carer counselling.
3
Appraise current Australian guidelines (ATAGI and state/territory programs) for maternal RSV vaccination and monoclonal antibody prophylaxis.
4
Formulate evidence-based management plans for infants and children with recurrent post-viral wheeze following RSV infection, including referral criteria and thresholds for initiating preventative asthma therapy.
5
Identify Australian populations at highest risk of severe RSV disease and long-term respiratory sequelae, including Aboriginal and Torres Strait Islander children and those with relevant comorbidities.
Learning Outcomes
Upon completion of this education you will be able to:
-
Identify patients who meet the eligibility requirements for bariatric surgery and apply evidence-based referral criteria.
-
Outline the GP’s role in pre-operative and long-term management of bariatric patients.
-
Recognise common spine presentations in general practice and determine when urgent surgical referral is required.
-
Apply collaborative, evidence-based strategies to optimise patient outcomes in bariatric and spine surgery.
Pre-register your interest in this education
This groundbreaking education is coming very soon. Be the first to hear about it when it does! By registering your interest below we'll let you know as soon as it's available in Praxhub.
The details provided by you will only be used for the purpose of notifying you when these activities and resources become available. If you have questions regarding the collection or use of your information, please contact privacy@praxhub.com.
Expert Presenters
_edited.png)
Continuing Professional Development (CPD) Details
This medical education activity has been approved for 1.5 Educational Activity hours, 5 Measuring Outcomes hours and 1 Reviewing Performance hour with:
Activity ID: 1595315
Activity ID: 2377
Activity ID: 41744
Automatic hours lodgement
RACGP and AMA/CPDHome members can now enjoy the convenience of rapid, automatic EA hours lodgement for this education. See your completed hours lodged within 24 hours.*
* Requires correct membership details.
Update yours now >
Please note that any additional reading or learning connected to this activity can be self recorded with your CPD body.
Praxhub is an accredited Major Provider under the RACGP CPD Program.
Praxhub is a Certified Learning Provider under the AMA's CPDHome CPD Program.
References:
-
Crawford, N.W. et al. (2025) 'Study of Children Aged Under 2 Years Admitted With RSV at Four Australian Hospitals [2021–2022]', Journal of Paediatrics and Child Health, 61, p. 482.
-
Immunisation Coalition (2024) Record RSV Cases in 2024 Prompt Vital RSV Vaccine Addition to the National Immunisation Program. Available at: https://www.immunisationcoalition.org.au/.
-
Driscoll, A.J. et al. (2020) 'Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting', Vaccine, 38, pp. 2435–2448.
-
Asseri, A.A. (2025) 'Respiratory Syncytial Virus: A Narrative Review of Updates and Recent Advances in Epidemiology, Pathogenesis, Diagnosis, Management and Prevention', Journal of Clinical Medicine, 14, p. 3880.
